Harrow to Present at Two Investor Conferences in November

About this update from Harrow, Inc.

[{"type":"text","content":" NASHVILLE, Tenn.--(BUSINESS WIRE)--\nHarrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the following two upcoming conferences:\n\n\nBTIG 3rd Annual Ophthalmology Day\nFormat: Fireside Chat (Virtual)\nDate/Time: Monday, November 27, 2023, at 1:30 p.m. ET\n\n\nPiper Sandler 35th Annual Healthcare Conference (The Lotte New York Palace, New York, NY)\nFormat: Fireside Chat (In-Person)\nDate/Time: Thursday, November 30, 2023, at 8:00 a.m. ET\n\n\nHarrow management will be available for one-on-one meetings during both conferences. Investors interested in meeting with management should contact their BTIG or Piper Sandler representative to request a meeting.\n\n\nAbout Harrow\n\n\nHarrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans each year. For more information about Harrow, please visit harrow.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20231120551397/en/\n\nJamie Webb, Director of Communications and Investor Relations\[email protected]\n615-733-4737\n\n\nSource: Harrow, Inc.","length":2737,"tagName":"div"}]

More updates from Harrow, Inc.